Results 121 to 130 of about 30,950 (250)

Massive Desmoplastic Fibroma of the Proximal Tibia: Case Report [PDF]

open access: yes
Desmoplastic fibroma; Orthopedic; TibiaFibroma desmoplásico; Ortopedia; TibiaFibroma desmoplàstic; Ortopèdia; TíbiaDesmoplastic fibroma of bone is a very uncommon, benign but locally aggressive fibrogenic tumor.
Romagosa, Cleofé   +5 more
core   +1 more source

Sex‐Modulated TACSTD2 Methylation and Hormone‐Receptor Axis Interactions in Glioblastoma: Insights Toward Mechanistic Understanding

open access: yesComputational and Systems Oncology, Volume 6, Issue 1, December 2026.
Sex‐stratified analyses of the TCGA and CGGA cohorts have identified promoter‐proximal TACSTD2 CpG sites where methylation shows opposite survival associations in males and females, is independent of copy number, and correlates with TACSTD2 expression.
Tahreem Fatima
wiley   +1 more source

Genetic Testing Station Provides Increased Access to Germline Genetic Testing for Pediatric Oncology Patients

open access: yesJournal of Genetic Counseling, Volume 35, Issue 6, December 2026.
ABSTRACT Germline genetic testing in the pediatric oncology population remains under‐utilized, despite evidence that 10%–15% of these patients have an underlying genetic cause. Identifying patients with a genetic predisposition can affect diagnosis, treatment, and future surveillance of the patient and family.
Camille Hamilton   +14 more
wiley   +1 more source

Patients with Desmoplastic Melanoma May Respond to PD-1 Blockade

open access: yes, 2018
PD-1 blockade achieved responses in 70% of patients with desmoplastic melanoma in a retrospective analysis.

core   +1 more source

Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang   +16 more
wiley   +1 more source

Desmoplastic malignant melanoma on the buttock of an 18-year-old girl: Differentiation from desmoplastic nevus

open access: yes, 1999
Melanocytic proliferation in young people may sometimes pose a diagnostic dilemma. This is particularly so when a desmoplastic component is present. Because the two main differential diagnoses, desmoplastic malignant melanoma and desmoplastic Spitz nevus,
Chan, GSW, Ng, WK, Choy, C, Chan, KW
core   +1 more source

Squamoid Eccrine Ductal Carcinoma: Case Series of a Rare, Potentially Aggressive Skin Cancer Associated With Immunosuppression

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 12, Page 1088-1096, December 2026.
ABSTRACT Squamoid Eccrine Ductal Carcinoma (SEDC) is a rare cutaneous adenexal carcinoma first described in 1997. It has distinct biphasic features on histology which commonly result in misdiagnosis as Bowen disease or cutaneous squamous cell carcinomas (cSCC) if diagnostic skin biopsies are too superficial. This may lead to a delay in diagnosis. It is
Xiang Li Tan   +15 more
wiley   +1 more source

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 12, Page 1131-1141, December 2026.
ABSTRACT Background Anti‐PD‐1 response has been associated with higher PD‐1 ligand (PD‐L1) expression levels in different cancer types. Cemiplimab, an anti‐PD‐1 antibody, has been shown to induce a response rate of 31% and 22% in patients with locally advanced basal cell carcinoma (BCC) and metastatic BCC respectively, who have progressed or are ...
Isabella Dommann   +9 more
wiley   +1 more source

Diagnostic Utility of PRAME Immunohistochemistry for Distinguishing Acral Melanoma From Acral Melanocytic Nevi

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 12, Page 1148-1158, December 2026.
ABSTRACT Introduction Preferentially expressed antigen in melanoma (PRAME) immunohistochemistry helps distinguish non‐acral melanocytic lesions, but few studies have addressed its value in acral lesions. We aimed to identify an optimal PRAME cut‐off score to differentiate acral melanoma (AM) from acral melanocytic nevi (AMN).
Kritsada Phatcharamaneepakorn   +4 more
wiley   +1 more source

Desmoplastic infantile ganglioglioma: case report

open access: yesThe Turkish Journal of Pediatrics, 2008
Desmoplastic infantile gangliogliomas are very rarely encountered, large supratentorial masses, derived from neuroepithelial origin, which have cystic and solid components and contain cells with astrocytic and ganglionic differentiation.
Emel Avci   +5 more
doaj  

Home - About - Disclaimer - Privacy